Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Illumina News

Aktie
WKN:  927079 ISIN:  US4523271090 US-Symbol:  ILMN Land:  USA
114,31 €
+1,67 €
+1,48%
17.04.26
Depot/Watchlist
Marktkapitalisierung *
18,15 Mrd. €
Streubesitz
-
KGV
28,17
Nachhaltigkeits-Score
66 %
Index-Zuordnung
Nasdaq Composite Index
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,12: VH7QSM
Werbung

Illumina News

13.01.26 - PR Newswire
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery PR Newswire
13.01.26 - PR Newswire
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 PR Newswire
12.01.26 - PR Newswire
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 PR Newswire
08.01.26 - PR Newswire
Illumina Appoints Dr. Eric Green as Chief Medical Officer
Illumina Appoints Dr. Eric Green as Chief Medical Officer PR Newswire
06.01.26 - PR Newswire
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis PR Newswire
16.12.25 - PR Newswire
Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference PR Newswire
11.12.25 - PR Newswire
/C O R R E C T I O N -- MyOme, Inc/
/C O R R E C T I O N -- MyOme, Inc/ PR Newswire
24.11.25 wallstreetONLINE Redaktion
Biotech rein, Chips raus: Cathie Wood: Die größte Portfolio-Umschichtung des Jahres – was ist da los?
Cathie Wood setzt auf eine neue Marktphase: ARK Invest kauft massiv Biotech und KI-​Infrastruktur und trennt sich von bekannten Tech- und Diagnostikwerten. Was steckt ...
12.11.25 - PR Newswire
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
Illumina whole-​genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study PR Newswire
11.11.25 - PR Newswire
Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference PR Newswire
10.11.25 - PR Newswire
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks PR Newswire
05.11.25 - PR Newswire
Illumina Responds to Positive Updates from Chinese Ministry of Commerce
Illumina Responds to Positive Updates from Chinese Ministry of Commerce PR Newswire
30.10.25 - PR Newswire
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 PR Newswire
15.10.25 - PR Newswire
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights PR Newswire
15.10.25 - PR Newswire
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina constellation mapped read technology uncovers hard-​to-see genomic insights in GeneDx pilot PR Newswire
14.10.25 - PR Newswire
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025 PR Newswire
01.10.25 - PR Newswire
Illumina launches new business to accelerate technology and data-driven discovery
Illumina launches new business to accelerate technology and data-​driven discovery PR Newswire
23.09.25 - PR Newswire
Illumina advances personalized cancer care with new pharma development partnerships
Illumina advances personalized cancer care with new pharma development partnerships PR Newswire
18.09.25 - PR Newswire
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine PR Newswire
15.09.25 - LYNX Analysen
Illumina: Endlich wieder auf Erfolgskurs?
Illumina hat eine turbulente Geschichte hinter sich. Die jüngsten Quartals­zahlen deuten jedoch auf eine Rückkehr zu alter Stärke hin. Jetzt vollständige Analyse lesen

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »